Bisphosphonate Therapy for Fracture Prevention: Time to Benefit |
Journal Updates
eMediNexus Coverage from: 
Bisphosphonate Therapy for Fracture Prevention: Time to Benefit

0 Read Comments                

A new meta-analysis determined around one year as the minimal timing of bisphosphonate therapy for postmenopausal women with osteoporosis to obtain benefit.Researchers analyzed 10 randomized clinical trials which involved 23,384 women. It was noted that 12.4 months on bisphosphonate therapy were needed to avoid one nonvertebral fracture per 100 postmenopausal women, with an absolute risk reduction (ARR) of 0.010. Moreover, protection against fracture seemed to improve over treatment duration. Th...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now